Gangrene of the genitals, Amputations, Kidney Damage, Ketoacidosis
Invokana can cause gangrene of the genitals, a flesh-eating genital infection sometimes known as necrotizing fasciitis or Fournier’s gangrene.
Invokana, Invokamet, Farxiga, and Jardiance – SGLT2 diabetes drugs – increase the risk of amputations. The FDA released this warning August 29, 2018:
The U.S. Food and Drug Administration (FDA) is warning that cases of a rare but serious infection of the genitals and area around the genitals have been reported with the class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (SGLT2) inhibitors. This serious rare infection, called necrotizing fasciitis of the perineum, is also referred to as Fournier’s gangrene. We are requiring a new warning about this risk to be added to the prescribing information of all SGLT2 inhibitors and to the patient Medication Guide.
Invokana Linked to Kidney Failure
According to the American Diabetes Association, ketoacidosis – also known as acidosis or diabetic ketoacidosis (DKA) – causes one to produce dangerous levels of blood acids, or keytones, which can lead to diabetic coma and can be fatal. The FDA is now reviewing the safety of all SGLT2 inhibitors to determine if the risk of ketoacidosis should be noted on the drugs’ labels, and also whether Invokana raises the risk of amputations.
Free Legal Consultation
Matthews & Associates is investigating potential Invokana lawsuits on behalf of anyone hospitalized due to gangrene of the genitals, ketoacidosis, diabetic ketoacidosis (DKA), ketosis, or acidosis while using Invokana, Invokamet, Farxiga, Jardiance, or another Type 2 diabetes medication known as sodium-glucose cotransporter-2 (SGLT2) inhibitors.
If you were hospitalized with infection or gangrene of the genitals after taking Invokana or a similar diabetes medication, or if you lost a limb or limbs after taking one of these drugs, contact our legal staff today for a free legal case review regarding a potential lawsuit against the drug’s maker. By filing an diabetes drug gangrene lawsuit, you may be able to obtain compensation for medical bills, lost wages, pain and suffering, and other damages related to your injuries.
Diabetes Type 2 Medications
- Invokana (canagliflozin)
- Invokamet (canagliflozin/metformin)
- Jardiance (empagliflozin)
- Xigduo XR (dapagliflozin/metformin)
- Farxiga (dapagliflozin)
- Glyxambi (empagliflozin/linagliptin)
FDA Warning for Type 2 Diabetes Meds Invokana, Invokamet
FDA reviewed 20 adverse event reports from people seriously injured or hospitalized after taking type 2 diabetes drugs that included Invokana and Invokamet. These drugs belong to a class of medications known as sodium-glucose cotransporter-2 (SGLT2) inhibitors. They were approved by FDA to lower blood sugar levels in adults suffering from type 2 diabetes.
The FDA announcement warned patients to seek immediate medical help for symptoms of ketoacidosis. Symptoms include several potentially serious health issues:
- Difficulty breathing
- Abdominal pain
- Unusual fatigue or sleepiness
What is Invokana?
• A prescription drug made by Janssen Pharmaceuticals, a division of Johnson & Johnson.
• A drug meant to lower blood sugar in type 2 diabetic adults
• Not for people with type 1 diabetes
• Not for those with diabetic ketoacidosis (increased ketones)
• Not proven safe and effective for children under 18.
Invokana hit the market in May 2013 with a heavy and successful marketing campaign. Johnson & Johnson reported 2014 sales of Invokana totaling $569 million. Sales for 2015 total $266 million as of June 2015. Those are heavy sales for any drug, much less one as new as Invokana.
Invokana Gangrene Lawsuit Attorney
Working nationwide, Matthews & Associates drug injury lawyers are ready to help those injured by gangrene of the genitals, or ketoacidosis after taking diabetes medication such as Invokana, Invokamet, Jardiance and others. Please see our testimonials or call us for a free legal consultation regarding a potential Invokana diabetes drug lawsuit.